Development of a Novel AAV-Based Therapy in Combination with Tolerogenic ImmTOR Nanoparticles for a Sustained Treatment of Ornithine Transcarbamylase Deficiency

HUMAN GENE THERAPY(2019)

引用 0|浏览26
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要